Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2010
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/21/2010CA2666446A1 Compositions for prostate and menstrual/menopausal related health
11/18/2010WO2010132743A1 Corticosteroid beta-agonist compounds for use in therapy
11/18/2010WO2010131191A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/18/2010WO2010102171A3 Secreted ap2 and methods of inhibiting same
11/18/2010WO2010065567A3 Methods and compositions for altering health, wellbeing, and lifespan
11/18/2010WO2010017965A3 SOLID LIPID MICROCAPSULES CONTAINING hGH
11/18/2010US20100292201 Novel steroidal esters of 17-oximino-5-androsten-3beta-ol
11/18/2010US20100292184 17beta-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivative
11/18/2010US20100292147 Identification of the hepcidin binding site on ferroportin
11/18/2010US20100292131 Biomarkers and methods for diagnosing, predicting and/or prognosing sepsis and uses thereof
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010CA2761853A1 Benzoxazolone derivatives as aldosterone synthase inhibitors
11/18/2010CA2761384A1 Treatment of stress
11/18/2010CA2758202A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/17/2010EP2251426A1 Mammalian-type glycosylation in plants
11/17/2010EP2251006A1 Microparticles and pharmaceutical compositions thereof
11/17/2010CN101888830A 透皮递送系统 Transdermal delivery systems
11/17/2010CN101884794A Application of S100A16 gene in preparing medicaments for treating insulin resistance
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884769A Traditional Chinese medicine for treating autoimmune thyroiditis and production method
11/17/2010CN101884639A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/11/2010WO2010128141A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
11/11/2010WO2010086129A8 Inclusion complex comprising cinacalcet and cyclodextrin
11/11/2010WO2010004299A3 Pharmaceutical compositions of somatotrophic hormones
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100286281 Methods and materials for the treatment of testosterone deficiency in men
11/11/2010US20100286267 Compounds for the treatment of metabolic disorders
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286182 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof
11/11/2010US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286034 Uses for aqueous streams containing proteins
11/11/2010US20100285163 Composition for Treating or Preventing Hot Flashes and use Thereof
11/11/2010US20100284912 Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients
11/10/2010EP2248524A2 Preventives/remedies for stress urinary incontinence and method of screening the same
11/10/2010EP2018169B1 Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010EP1460995B1 Transdermal transport of compounds
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN1552315B 治疗组合物 The therapeutic composition
11/10/2010CN101883778A Steroidal [3, 2-C] pyrazole compounds, with glucocorticoid activity
11/10/2010CN101883556A Transdermal delivery system for hormones and steroids
11/10/2010CN101002796B Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829595 A mixture of compound, e.g., cinacalcet hydrochloride and excipient in dosage form having a controlled dissolution profile , which comprises 50-125% of a target amount of theactive compound is released in 0.05 hydrochloric acid in 30 minutes; calcimimetics and calcilytics; hyperparathyroidism
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829115 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
11/09/2010US7829109 Catheter injectable depot compositions and uses thereof
11/09/2010CA2602198C Substituted triazole derivatives as oxytocin antagonists
11/09/2010CA2412899C Medicinal preparations for treating sex hormone-dependent diseases
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/09/2010CA2362794C Inhibitors of separase, method for identifying them and uses
11/04/2010WO2010126953A1 Corticosteroid linked beta-agonist compounds for use in therapy
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010125891A1 Estrogen-like agonist
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010124322A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280123 Food supplement containing alpha-keto acids for supporting diabetes therapy
11/04/2010US20100280102 Double-stranded ribonucleic acid with increased effectiveness in an organism
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280046 Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
11/04/2010US20100280004 Small molecule correctors of deltaf508 cftr trafficking
11/04/2010US20100279988 Transdermal delivery system for hormones and steroids
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279923 Therapeutic application of kazal-type serine protease inhibitors
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100278924 Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2759047A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/03/2010EP2245042A1 C20-c21 substituted glucocorticoid receptor agonists
11/03/2010EP1865990B1 Method of treating type-2 diabetes
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010CN101878221A Novel glucocorticoid receptor agonists
11/03/2010CN101874834A New application of processed products of Chinese goldthread stir-fried with rice vinegar
11/03/2010CN101874833A Novel application of wine-roasted Chinese goldthread processed product
11/03/2010CN101874831A New application of coptis product processed by ginger juice
11/03/2010CN101874830A New application of golden thread processed product
11/03/2010CN101874806A Dienogest solid preparation
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010CA2448244C Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
11/02/2010CA2416771C 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
10/2010
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122385A1 Fast-acting insulin formulation
10/28/2010WO2010078285A3 Pharmaceutical compositions and methods of treating neurological insults
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 290